BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 22078793)

  • 21. Automated 3-dimensional elastic registration of whole-body PET and CT from separate or combined scanners.
    Shekhar R; Walimbe V; Raja S; Zagrodsky V; Kanvinde M; Wu G; Bybel B
    J Nucl Med; 2005 Sep; 46(9):1488-96. PubMed ID: 16157532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.
    Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P
    Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Attenuation correction of PET images with respiration-averaged CT images in PET/CT.
    Pan T; Mawlawi O; Nehmeh SA; Erdi YE; Luo D; Liu HH; Castillo R; Mohan R; Liao Z; Macapinlac HA
    J Nucl Med; 2005 Sep; 46(9):1481-7. PubMed ID: 16157531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimized contrast-enhanced CT protocols for diagnostic whole-body 18F-FDG PET/CT: technical aspects of single-phase versus multiphase CT imaging.
    Brechtel K; Klein M; Vogel M; Mueller M; Aschoff P; Beyer T; Eschmann SM; Bares R; Claussen CD; Pfannenberg AC
    J Nucl Med; 2006 Mar; 47(3):470-6. PubMed ID: 16513616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PET/MRI in the Presence of Metal Implants: Completion of the Attenuation Map from PET Emission Data.
    Fuin N; Pedemonte S; Catalano OA; Izquierdo-Garcia D; Soricelli A; Salvatore M; Heberlein K; Hooker JM; Van Leemput K; Catana C
    J Nucl Med; 2017 May; 58(5):840-845. PubMed ID: 28126884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI.
    Schöder H; Carlson DL; Kraus DH; Stambuk HE; Gönen M; Erdi YE; Yeung HW; Huvos AG; Shah JP; Larson SM; Wong RJ
    J Nucl Med; 2006 May; 47(5):755-62. PubMed ID: 16644744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CT.
    Rauscher I; Eiber M; Fürst S; Souvatzoglou M; Nekolla SG; Ziegler SI; Rummeny EJ; Schwaiger M; Beer AJ
    J Nucl Med; 2014 May; 55(5):724-9. PubMed ID: 24652827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion-weighted MR imaging in comparison to integrated [¹⁸F]-FDG PET/CT for N-staging in patients with lung cancer.
    Pauls S; Schmidt SA; Juchems MS; Klass O; Luster M; Reske SN; Brambs HJ; Feuerlein S
    Eur J Radiol; 2012 Jan; 81(1):178-82. PubMed ID: 20932700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
    Börjesson PK; Jauw YW; Boellaard R; de Bree R; Comans EF; Roos JC; Castelijns JA; Vosjan MJ; Kummer JA; Leemans CR; Lammertsma AA; van Dongen GA
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2133-40. PubMed ID: 16609026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of a Dixon-based MR/PET attenuation correction sequence for the localization and evaluation of PET-positive lesions.
    Eiber M; Martinez-Möller A; Souvatzoglou M; Holzapfel K; Pickhard A; Löffelbein D; Santi I; Rummeny EJ; Ziegler S; Schwaiger M; Nekolla SG; Beer AJ
    Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1691-701. PubMed ID: 21688050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
    Beyer T; Bockisch A; Kühl H; Martinez MJ
    J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
    Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
    Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of attenuation correction in cardiac PET using PET/MR.
    Lau JMC; Laforest R; Sotoudeh H; Nie X; Sharma S; McConathy J; Novak E; Priatna A; Gropler RJ; Woodard PK
    J Nucl Cardiol; 2017 Jun; 24(3):839-846. PubMed ID: 26499770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up?
    Chen W; Jian W; Li HT; Li C; Zhang YK; Xie B; Zhou DQ; Dai YM; Lin Y; Lu M; Huang XQ; Xu CX; Chen L
    Magn Reson Imaging; 2010 Jun; 28(5):613-20. PubMed ID: 20418042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of partial volume correction in staging of head and neck squamous cell carcinoma using PET/CT.
    Fayad H; Le Pogam A; Lamare F; Fernandez P; Pradier O; Valette G; Visvikis D; Cheze Le Rest C
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):319-28. PubMed ID: 25265252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 18F-FDG PET/CT for staging of penile cancer.
    Scher B; Seitz M; Reiser M; Hungerhuber E; Hahn K; Tiling R; Herzog P; Reiser M; Schneede P; Dresel S
    J Nucl Med; 2005 Sep; 46(9):1460-5. PubMed ID: 16157528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-body PET/MRI: the effect of bone attenuation during MR-based attenuation correction in oncology imaging.
    Aznar MC; Sersar R; Saabye J; Ladefoged CN; Andersen FL; Rasmussen JH; Löfgren J; Beyer T
    Eur J Radiol; 2014 Jul; 83(7):1177-1183. PubMed ID: 24780817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
    Schmidt GP; Kramer H; Reiser MF; Glaser C
    Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone.
    Andersen FL; Ladefoged CN; Beyer T; Keller SH; Hansen AE; Højgaard L; Kjær A; Law I; Holm S
    Neuroimage; 2014 Jan; 84():206-16. PubMed ID: 23994317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.